Showing results (601-610 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|September 28, 2016
Relationship between vitamin D receptor gene polymorphisms, cardiovascular risk factors and adiponectin in a healthy young populationAline Hajj, Rima Chedid, Eliane Chouery, et al.Pharmacogenomics|September 28, 2016
RICTOR polymorphisms affect efficiency of platinum-based chemotherapy in Chinese non-small-cell lung cancer patientsShiming Wang, Xiao Song, Xiaoying Li, et al.Pharmacogenomics|March 29, 2008
Pharmacogenomics of metabolic effects of rosiglitazoneOndrej Seda, Lucie Sedová, Olena Oliyarnyk, et al.Pharmacogenomics|March 29, 2008
Epigenetics of cancer progressionEmily A Vucic, Carolyn J Brown, Wan L LamPharmacogenomics|March 29, 2008
DNAPrint Genomics, Inc.: better drugs for segmented marketsTony FrudakisPharmacogenomics|April 29, 2015
SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterizationJosephine H Li, Sunil Suchindran, Svati H Shah, et al.Pharmacogenomics|April 29, 2015
Relationship between mRNA expression levels of CYP3A4, CYP3A5 and SXR in peripheral mononuclear blood cells and aging in young kidney transplant recipients under tacrolimus treatmentMariano Ferraresso, Stefano Turolo, Mirco Belingheri, et al.Pharmacogenomics|April 29, 2015
Pharmacogenomics of cyclooxygenasesJosé A G Agúndez, Miguel Blanca, José A Cornejo-García, et al.Pharmacogenomics|August 25, 2016
Plasma miR-142 accounting for the missing heritability of CYP3A4/5 functionality is associated with pharmacokinetics of clopidogrelQian-Jie Tang, Hao-Ming Lin, Guo-Dong He, et al.Pharmacogenomics|April 16, 2021
Personal genotyping and student outcomes in genetic and pharmacogenetic teaching: a systematic review and meta-analysisKyle J Burghardt, Kristen M Ward, Bradley H Howlett, et al.Pageof 276